BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bovenberg MS, Degeling MH, Tannous BA. Advances in stem cell therapy against gliomas. Trends Mol Med 2013;19:281-91. [PMID: 23537753 DOI: 10.1016/j.molmed.2013.03.001] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 4.4] [Reference Citation Analysis]
Number Citing Articles
1 Sun R, Kim AH. The multifaceted mechanisms of malignant glioblastoma progression and clinical implications. Cancer Metastasis Rev 2022. [PMID: 35920986 DOI: 10.1007/s10555-022-10051-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Bomba HN, Carey‐ewend A, Sheets KT, Valdivia A, Goetz M, Findlay IA, Mercer‐smith A, Kass LE, Khagi S, Hingtgen SD. Use of FLOSEAL ® as a scaffold and its impact on induced neural stem cell phenotype, persistence, and efficacy. Bioengineering & Transla Med. [DOI: 10.1002/btm2.10283] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Mo F, Pellerino A, Soffietti R, Rudà R. Blood-Brain Barrier in Brain Tumors: Biology and Clinical Relevance. Int J Mol Sci 2021;22:12654. [PMID: 34884457 DOI: 10.3390/ijms222312654] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
4 Yudintceva N, Lomert E, Mikhailova N, Tolkunova E, Agadzhanian N, Samochernych K, Multhoff G, Timin G, Ryzhov V, Deriglazov V, Mazur A, Shevtsov M. Targeting Brain Tumors with Mesenchymal Stem Cells in the Experimental Model of the Orthotopic Glioblastoma in Rats. Biomedicines 2021;9:1592. [PMID: 34829821 DOI: 10.3390/biomedicines9111592] [Reference Citation Analysis]
5 Mahjoor M, Afkhami H, Mollaei M, Nasr A, Shahriary S, Khorrami S. MicroRNA-30c delivered by bone marrow-mesenchymal stem cells induced apoptosis and diminished cell invasion in U-251 glioblastoma cell line. Life Sci 2021;279:119643. [PMID: 34048811 DOI: 10.1016/j.lfs.2021.119643] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
6 Andreou T, Williams J, Brownlie RJ, Salmond RJ, Watson E, Shaw G, Melcher A, Wurdak H, Short SC, Lorger M. Hematopoietic stem cell gene therapy targeting TGFβ enhances the efficacy of irradiation therapy in a preclinical glioblastoma model. J Immunother Cancer 2021;9:e001143. [PMID: 33707311 DOI: 10.1136/jitc-2020-001143] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
7 Zhou X, Smith QR, Liu X. Brain penetrating peptides and peptide-drug conjugates to overcome the blood-brain barrier and target CNS diseases. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2021;13:e1695. [PMID: 33470550 DOI: 10.1002/wnan.1695] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 25.0] [Reference Citation Analysis]
8 Amero P, Khatua S, Rodriguez-Aguayo C, Lopez-Berestein G. Aptamers: Novel Therapeutics and Potential Role in Neuro-Oncology. Cancers (Basel) 2020;12:E2889. [PMID: 33050158 DOI: 10.3390/cancers12102889] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
9 Xie Y, Liu W, Liu S, Wang L, Mu D, Cui Y, Cui Y, Wang B. The quality evaluation system establishment of mesenchymal stromal cells for cell-based therapy products. Stem Cell Res Ther 2020;11:176. [PMID: 32404162 DOI: 10.1186/s13287-020-01696-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
10 Carvalho LA, Teng J, Fleming RL, Tabet EI, Zinter M, de Melo Reis RA, Tannous BA. Olfactory Ensheathing Cells: A Trojan Horse for Glioma Gene Therapy. J Natl Cancer Inst 2019;111:283-91. [PMID: 30257000 DOI: 10.1093/jnci/djy138] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
11 Affinito A, Quintavalle C, Esposito CL, Roscigno G, Giordano C, Nuzzo S, Ricci-Vitiani L, Scognamiglio I, Minic Z, Pallini R, Berezovski MV, de Francisis V, Condorelli G. Targeting Ephrin Receptor Tyrosine Kinase A2 with a Selective Aptamer for Glioblastoma Stem Cells. Mol Ther Nucleic Acids 2020;20:176-85. [PMID: 32169805 DOI: 10.1016/j.omtn.2020.02.005] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
12 Qi SG, Quan LQ, Cui XY, Li HM, Zhao XD, Li RT. A natural compound obtained from Valeriana jatamansi selectively inhibits glioma stem cells. Oncol Lett 2020;19:1384-92. [PMID: 32002029 DOI: 10.3892/ol.2019.11239] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
13 Arvanitis CD, Ferraro GB, Jain RK. The blood-brain barrier and blood-tumour barrier in brain tumours and metastases. Nat Rev Cancer 2020;20:26-41. [PMID: 31601988 DOI: 10.1038/s41568-019-0205-x] [Cited by in Crossref: 489] [Cited by in F6Publishing: 519] [Article Influence: 163.0] [Reference Citation Analysis]
14 Taverner WK, Jacobus EJ, Christianson J, Champion B, Paton AW, Paton JC, Su W, Cawood R, Seymour LW, Lei-Rossmann J. Calcium Influx Caused by ER Stress Inducers Enhances Oncolytic Adenovirus Enadenotucirev Replication and Killing through PKCα Activation. Mol Ther Oncolytics 2019;15:117-30. [PMID: 31890865 DOI: 10.1016/j.omto.2019.09.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
15 Affinito A, Quintavalle C, Esposito CL, Roscigno G, Vilardo C, Nuzzo S, Ricci-Vitiani L, De Luca G, Pallini R, Kichkailo AS, Lapin IN, de Franciscis V, Condorelli G. The Discovery of RNA Aptamers that Selectively Bind Glioblastoma Stem Cells. Mol Ther Nucleic Acids 2019;18:99-109. [PMID: 31541799 DOI: 10.1016/j.omtn.2019.08.015] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 7.0] [Reference Citation Analysis]
16 Carvalho LA, Tannous BA. Olfactory ensheathing cells travel their natural nasal pathway to deliver therapeutics to brain tumors. Oncotarget 2019;10:4351-3. [PMID: 31320988 DOI: 10.18632/oncotarget.27043] [Reference Citation Analysis]
17 Ma Z, Cui X, Lu L, Chen G, Yang Y, Hu Y, Lu Y, Cao Z, Wang Y, Wang X. Exosomes from glioma cells induce a tumor-like phenotype in mesenchymal stem cells by activating glycolysis. Stem Cell Res Ther 2019;10:60. [PMID: 30770778 DOI: 10.1186/s13287-019-1149-5] [Cited by in Crossref: 35] [Cited by in F6Publishing: 39] [Article Influence: 11.7] [Reference Citation Analysis]
18 Yang J, Yang Y, Kawazoe N, Chen G. Encapsulation of individual living cells with enzyme responsive polymer nanoshell. Biomaterials 2019;197:317-26. [PMID: 30685690 DOI: 10.1016/j.biomaterials.2019.01.029] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 11.3] [Reference Citation Analysis]
19 Wildes TJ, Flores CT, Mitchell DA. Concise Review: Modulating Cancer Immunity with Hematopoietic Stem and Progenitor Cells. Stem Cells 2019;37:166-75. [PMID: 30353618 DOI: 10.1002/stem.2933] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
20 Zhang Q, Xiang W, Yi DY, Xue BZ, Wen WW, Abdelmaksoud A, Xiong NX, Jiang XB, Zhao HY, Fu P. Current status and potential challenges of mesenchymal stem cell-based therapy for malignant gliomas. Stem Cell Res Ther 2018;9:228. [PMID: 30143053 DOI: 10.1186/s13287-018-0977-z] [Cited by in Crossref: 37] [Cited by in F6Publishing: 41] [Article Influence: 9.3] [Reference Citation Analysis]
21 Ho P, Chen YY. Synthetic Biology in Immunotherapy and Stem Cell Therapy Engineering. Synthetic Biology 2018. [DOI: 10.1002/9783527688104.ch17] [Reference Citation Analysis]
22 Zhu T, Xie P, Gao YF, Huang MS, Li X, Zhang W, Zhou HH, Liu ZQ. Nucleolar and spindle-associated protein 1 is a tumor grade correlated prognosis marker for glioma patients. CNS Neurosci Ther 2018;24:178-86. [PMID: 29336114 DOI: 10.1111/cns.12803] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 5.3] [Reference Citation Analysis]
23 Cao M, Mao J, Duan X, Lu L, Zhang F, Lin B, Chen M, Zheng C, Zhang X, Shen J. In vivo tracking of the tropism of mesenchymal stem cells to malignant gliomas using reporter gene-based MR imaging. Int J Cancer 2018;142:1033-46. [PMID: 29047121 DOI: 10.1002/ijc.31113] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 4.6] [Reference Citation Analysis]
24 Tan B, Shen L, Yang K, Huang D, Li X, Li Y, Zhao L, Chen J, Yi Q, Xu H, Tian J, Zhu J. C6 glioma-conditioned medium induces malignant transformation of mesenchymal stem cells: Possible role of S100B/RAGE pathway. Biochem Biophys Res Commun 2018;495:78-85. [PMID: 29050939 DOI: 10.1016/j.bbrc.2017.10.071] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
25 Erkan EP, Eren E, Genc S, Genc KK. Stem Cell-Based Approaches for Treatment of Glioblastoma. Stem Cells in Clinical Applications 2017. [DOI: 10.1007/978-3-319-33720-3_4] [Reference Citation Analysis]
26 de Paula LB, Primo FL, Pinto MR, Morais PC, Tedesco AC. Evaluation of a chloroaluminium phthalocyanine-loaded magnetic nanoemulsion as a drug delivery device to treat glioblastoma using hyperthermia and photodynamic therapy. RSC Adv 2017;7:9115-22. [DOI: 10.1039/c6ra26105a] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 5.6] [Reference Citation Analysis]
27 Hersh DS, Wadajkar AS, Roberts N, Perez JG, Connolly NP, Frenkel V, Winkles JA, Woodworth GF, Kim AJ. Evolving Drug Delivery Strategies to Overcome the Blood Brain Barrier. Curr Pharm Des 2016;22:1177-93. [PMID: 26685681 DOI: 10.2174/1381612822666151221150733] [Cited by in Crossref: 168] [Cited by in F6Publishing: 183] [Article Influence: 28.0] [Reference Citation Analysis]
28 Liubich L, Lisyany M, Malysheva T, Semenova V, Staino L, Vaslovich V. Morphometric characteristics of TGF-β1-positive cells of fetal rat brain in vitro. JCOT 2016;4:211-215. [DOI: 10.22494/cot.v4i2.58] [Reference Citation Analysis]
29 Liubich LD, Semenova VM, Malysheva TA, Stayno LP, Vaslovich VV. Effects of a Supernatant of Fetal Neurogenic Cells on Proliferative Activity in Glioma C6 Cell Culture. Neurophysiology 2016;48:238-45. [DOI: 10.1007/s11062-016-9594-6] [Reference Citation Analysis]
30 Feng X, Yu Y, He S, Cheng J, Gong Y, Zhang Z, Yang X, Xu B, Liu X, Li CY, Tian L, Huang Q. Dying glioma cells establish a proangiogenic microenvironment through a caspase 3 dependent mechanism. Cancer Lett 2017;385:12-20. [PMID: 27826040 DOI: 10.1016/j.canlet.2016.10.042] [Cited by in Crossref: 51] [Cited by in F6Publishing: 57] [Article Influence: 8.5] [Reference Citation Analysis]
31 Londono R, Badylak SF. Biomaterials from Decellularized Tissues. Biomaterials from Nature for Advanced Devices and Therapies 2016. [DOI: 10.1002/9781119126218.ch12] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
32 Kim SM, Jeong CH, Woo JS, Ryu CH, Lee JH, Jeun SS. In vivo near-infrared imaging for the tracking of systemically delivered mesenchymal stem cells: tropism for brain tumors and biodistribution. Int J Nanomedicine. 2015;11:13-23. [PMID: 26719691 DOI: 10.2147/ijn.s97073] [Cited by in Crossref: 21] [Cited by in F6Publishing: 31] [Article Influence: 3.0] [Reference Citation Analysis]
33 Krasikova LS, Karshieva SS, Cheglakov IB, Belyavsky AV. Mesenchymal stem cells expressing cytosine deaminase inhibit growth of murine melanoma B16F10 in vivo. Mol Biol 2015;49:904-11. [DOI: 10.1134/s0026893315060126] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
34 Teng J, Hejazi S, Badr CE, Tannous BA. Systemic anticancer neural stem cells in combination with a cardiac glycoside for glioblastoma therapy. Stem Cells. 2014;32:2021-2032. [PMID: 24801379 DOI: 10.1002/stem.1727] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
35 Liubich L, SI «A.P. Romodanov Institute of Neurosurgery NAMS of Ukraine”, Kyiv, Lisyany N, SI «A.P. Romodanov Institute of Neurosurgery NAMS of Ukraine”, Kyiv. THE INFLUENCE OF PROGENITOR NEUROCELLS SUPERNATANT ON THE LYMPHOCYTES CYTOTOXIC FUNCTION IN RATS WITH GLIOMA. Fiziol Zh 2015;61:63-70. [DOI: 10.15407/fz61.04.063] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
36 Liubich LD, Semenova VM, Stayno LP. Influence of rat progenitor neurogenic cells supernatant on glioma 101.8 cells in vitro. Biopolym Cell 2015;31:200-208. [DOI: 10.7124/bc.0008e1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
37 Lyubich L, Lisyany M. Effects of the neurogenic cells supernatant on the tumor-inducing ability of glioma 101.8 in rats. JCOT 2015;3:57-61. [DOI: 10.22494/cot.v3i1.17] [Reference Citation Analysis]
38 Zhang F, Xu CL, Liu CM. Drug delivery strategies to enhance the permeability of the blood-brain barrier for treatment of glioma. Drug Des Devel Ther 2015;9:2089-100. [PMID: 25926719 DOI: 10.2147/DDDT.S79592] [Cited by in Crossref: 84] [Cited by in F6Publishing: 87] [Article Influence: 12.0] [Reference Citation Analysis]
39 Burns TC, Verfaillie CM. From mice to mind: Strategies and progress in translating neuroregeneration. Eur J Pharmacol 2015;759:90-100. [PMID: 25814255 DOI: 10.1016/j.ejphar.2015.03.041] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
40 Prasad V, Suomalainen M, Pennauer M, Yakimovich A, Andriasyan V, Hemmi S, Greber UF. Chemical induction of unfolded protein response enhances cancer cell killing through lytic virus infection. J Virol 2014;88:13086-98. [PMID: 25187554 DOI: 10.1128/JVI.02156-14] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 3.3] [Reference Citation Analysis]
41 Basel MT, Shrestha TB, Bossmann SH, Troyer DL. Cells as delivery vehicles for cancer therapeutics. Therapeutic Delivery 2014;5:555-67. [DOI: 10.4155/tde.14.24] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]